HemCheck Sweden AB (publ.) has developed and marketed a product that detects haemolysis in blood samples at the point of care, based in Karlstad, Sweden. HemCheck is listed on the Nasdaq First North Growth Market in Stockholm.

HemCheck was founded in 2010 based on an invention by Dr. Mathias Karlsson. HemCheck’s market is global and the number of blood tests relevant to HemCheck is approximately 2 billion. HemCheck’s Helge product is protected by patents in the US and Europe.